COVID-19-Associated Critical Illness Myopathy with Direct Viral Effects

Ann Neurol. 2022 Apr;91(4):568-574. doi: 10.1002/ana.26318. Epub 2022 Feb 28.

Abstract

Coronavirus disease 2019 (COVID-19) severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2 infection) can lead to intensive care unit (ICU) admission and critical illness myopathy (CIM). We examined 3 ICU patients with COVID-19 who required mechanical ventilation for pneumonia and developed CIM. Pathological examination of the skeletal muscle biopsies revealed myopathic changes consistent with CIM, variable inflammation with autophagic vacuoles, SARS-CoV immunostaining + fibers/granules, and electron microscopy findings of mitochondrial abnormalities and coronavirus-like particles. Although mitochondrial dysfunction with compromised energy production is a critical pathogenic mechanism of non-COVID-19-associated CIM, in our series of COVID-19-associated CIM, myopathic changes including prominent mitochondrial damage suggest a similar mechanism and association with direct SARS-CoV-2 muscle infection. ANN NEUROL 2022;91:568-574.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Autophagy
  • COVID-19 / complications*
  • COVID-19 / virology*
  • Critical Illness*
  • Fatal Outcome
  • Female
  • Humans
  • Inflammation / pathology
  • Intensive Care Units
  • Male
  • Middle Aged
  • Mitochondria / pathology
  • Muscle, Skeletal / pathology
  • Muscular Diseases / etiology*
  • Muscular Diseases / virology*
  • SARS-CoV-2*
  • Vacuoles / pathology